Navigation Links
SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
Date:10/17/2007

sults to differ materially from the results discussed in these statements. Factors that might cause the company's results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, the ability to discover, develop and move target compounds into clinical development and other risks and uncertainties detailed from time to time in the company's filings with the Securities and Exchange Commission including its most recently filed Form 10-Q and 10-K. SuperGen, Inc. undertakes no duty to update any of these forward-looking statements to conform them to actual results.

Contacts

Timothy L. Enns Mary M. Vegh

SuperGen, Inc. SuperGen, Inc.

SVP, Corporate Communications Manager, Investor Relations

& Business Development Tel: (925) 560-2845

Tel: (925) 560-0100 E-mail: mary.vegh@supergen.com

E-mail: tenns@supergen.com


'/>"/>
SOURCE SuperGen Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Chennai AIDS Campaign Highlights The Social Neglect Faced By Victims
2. Benzene Slick In China Highlights Water Pollution
3. India To Highlight Its Scientific Achievements
4. Homecare Association Highlights Cost-Effectiveness of Medicare and Medicaid
5. India To Highlight The Potential Role Of Ayurveda In London
6. Study Highlights Appetite Regulation Pathway, New Hope for Weight Loss
7. Study Highlights How Bacteria Respond To Changes In Environment
8. Drug Action Week to Highlight Effects of Alcohol
9. Clinton, Gates Highlight Treatment, Discrimination of AIDS
10. Highlights from World Transplant Congress
11. Latest IPCC Report Highlights Need for Integrated Climate/human Behavior Models
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 2Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 3Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 4Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 2Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 3Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 4Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 5Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 6Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies 7Hobby Lobby Selects Concentra to Open Health Center 62350 1Hobby Lobby Selects Concentra to Open Health Center 62350 2Hobby Lobby Selects Concentra to Open Health Center 62350 3Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 62348 1Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 62348 2Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 62348 3Nations Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 62346 1Nations Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 62346 2Nations Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 62346 3